Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin
Metrics: PDF 601 views | Full Text 819 views | ?
Keita Kojima1, Naoko Minatani1, Hideki Ushiku1, Satoru Ishii1, Toshimichi Tanaka1, Keigo Yokoi1, Nobuyuki Nishizawa1, Yosuke Ooizumi1, Kazuharu Igarashi1, Kei Hosoda1, Hiromitsu Moriya1, Hiroaki Mieno1, Masahiko Watanabe1 and Keishi Yamashita1,2
1 Department of Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0329, Japan
2 Division of Advanced Surgical Oncology, Research and Development Center for New Frontier, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0329, Japan
Keywords: remnant gastric cancer; cysteine dioxygenase 1 (CDO1); homeodomain-only protein X (HOPX); Reprimo; E-cadherin
Received: September 17, 2018 Accepted: January 19, 2019 Published: March 29, 2019
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.